| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/26/2007 | WO2007047256A2 Svv-based animal vaccines and uses thereof |
| 04/26/2007 | WO2007047148A1 Minimal bacterial genome |
| 04/26/2007 | WO2007047141A2 Transgenic ro s a26-luc i f eras e mice for bioluminescent imaging |
| 04/26/2007 | WO2007047016A2 Methods for producing hybrid seed |
| 04/26/2007 | WO2007046943A2 Method of producing biotin |
| 04/26/2007 | WO2007046817A1 A mortierella alpina c16/18 fatty acid elongase |
| 04/26/2007 | WO2007046703A2 Improved aav vectors produced in insect cells |
| 04/26/2007 | WO2007046634A1 Method for preparing recombinant peptide from spider venom and analgesic composition containing the peptide |
| 04/26/2007 | WO2007046556A1 Novel dna polymerase |
| 04/26/2007 | WO2007046538A1 Method for ubiquitination of consensus subunit in rna polymerases |
| 04/26/2007 | WO2007046520A1 Method for screening of protein using immobilized puromycin linker |
| 04/26/2007 | WO2007046472A1 Method of measuring polymerization degree of protein |
| 04/26/2007 | WO2007046463A1 Atopic dermatitis marker and technique of using the same |
| 04/26/2007 | WO2007046439A1 Transgenic silkworm capable of producing antibody and method for production thereof |
| 04/26/2007 | WO2007046417A1 METHOD OF CONVERTING L-ARABINOSE INTO α-KETOGLUTARIC ACID, ENZYMES TO BE USED IN THE METHOD, GENES ENCODING THE ENZYMES AND RECOMBINANT MICROORGANISM CONTAINING THE GENES |
| 04/26/2007 | WO2007046403A1 Plant belonging to genus oryza having dominant dwarf trait, and use thereof |
| 04/26/2007 | WO2007046398A1 Stem cell-specific promoter |
| 04/26/2007 | WO2007046389A1 Process for production of succinic acid |
| 04/26/2007 | WO2007046158A1 Method of analyzing nucleic acid |
| 04/26/2007 | WO2007046148A1 Novel aromatic acyl group transferase gene |
| 04/26/2007 | WO2007045930A2 Modulation of trpv expression levels |
| 04/26/2007 | WO2007045927A2 Therapeutic agent |
| 04/26/2007 | WO2007045911A1 Integral membrane protein |
| 04/26/2007 | WO2007045799A1 Method for screening a proteasome activity modulating agent and means for carrying out said method |
| 04/26/2007 | WO2007045681A1 Method for the isolation of mrna from formalin fixed, paraffin-embedded tissue |
| 04/26/2007 | WO2007045476A2 Organic compounds |
| 04/26/2007 | WO2007045465A1 Method for the recombinant expression of a polypeptide |
| 04/26/2007 | WO2007045419A1 Method for the creation of genetic diversity in vivo |
| 04/26/2007 | WO2007045248A1 Use of fungal mutants for expression of antibodies |
| 04/26/2007 | WO2007045210A1 Method for determining l-serine, gene sequence, vectors and micro-organisms |
| 04/26/2007 | WO2007045160A1 Gene cry7bal encoding an insecticidal crystal protein of bacillus thuringiensis |
| 04/26/2007 | WO2007045062A2 Plasmid expression vectors for expression of recombinant rotavirus and astrovirus proteins or epitopes. |
| 04/26/2007 | WO2007045045A1 Antiviral resistance mutants and applications thereof |
| 04/26/2007 | WO2007024668A3 Targeting of herpes simplex virus to specific receptors |
| 04/26/2007 | WO2007022369A8 Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| 04/26/2007 | WO2007012944A3 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/26/2007 | WO2007005733A3 Novel peptides promoting neurite outgrowth |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | WO2007003675A3 Experimental neuroinflammation model, method of obtaining same and applications thereof |
| 04/26/2007 | WO2007002267A3 Nucleotide sequences mediating plant male fertility and method of using same |
| 04/26/2007 | WO2007002081A3 Gfats as modifiers of the axin pathway and methods of use |
| 04/26/2007 | WO2007001081A3 Method , array , apparatus and test system to discriminate individuals |
| 04/26/2007 | WO2007000671A3 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 04/26/2007 | WO2006133795A3 A new human t-cell lymphotropic virus (htlv-3): nucleic acid and peptidic sequences thereof and method for detecting htlv-3 |
| 04/26/2007 | WO2006129191A3 A method for optimized production of a recombinant form of tissue plasminogen activator |
| 04/26/2007 | WO2006121422A8 Antibodies against clostridium difficile toxins and uses thereof |
| 04/26/2007 | WO2006119432A3 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes |
| 04/26/2007 | WO2006114700A3 Method of producing human igg antibodies with enhanced effector functions |
| 04/26/2007 | WO2006113957A8 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 04/26/2007 | WO2006111924A3 Transformed plants accumulating terpenes |
| 04/26/2007 | WO2006107761A3 Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use |
| 04/26/2007 | WO2006104615A3 Influenza nucleic acids, polypeptides, and uses thereof |
| 04/26/2007 | WO2006081546A3 Inhibitor nucleic acids |
| 04/26/2007 | WO2006071896A3 Epitope-based sars vaccine |
| 04/26/2007 | WO2006055898A3 Orthogonal suppressor trnas and aminoacyl-trna synthetases and uses thereof |
| 04/26/2007 | WO2006033708A3 Biotic and abiotic stress tolerance in plants |
| 04/26/2007 | WO2006020663A3 Aerobic succinate production in bacteria |
| 04/26/2007 | WO2006011151A8 Vaccine comprising recombinant ct or lt toxin |
| 04/26/2007 | WO2005099770A3 Pancreatic islet microrna and methods for inhibiting same |
| 04/26/2007 | WO2005091777A3 Methods and materials relating to insulin growth factor-like (igfl) polypeptides and polynucleotides |
| 04/26/2007 | WO2005089102A3 Methods of refolding mammalian glycosyltransferases |
| 04/26/2007 | WO2005041859A3 Conjugates and compositions for cellular delivery. |
| 04/26/2007 | US20070094753 Polycomb genes from maize- Mez1 and Mez2 |
| 04/26/2007 | US20070094752 Using vector transformation to generate transgenic plants with enhanced freeze, salt and drought resistance |
| 04/26/2007 | US20070094751 Altered metabolism |
| 04/26/2007 | US20070094750 Novel ADC polynucleotides and polypeptides, uses thereof including methods for improving seeds |
| 04/26/2007 | US20070094749 Method for producing ketocarotinoids in plant fruit |
| 04/26/2007 | US20070094748 Recombinant DNA constructs and methods for controlling gene expression |
| 04/26/2007 | US20070094747 Inbred Corn Line PHCAM |
| 04/26/2007 | US20070094746 Hybrid caulimovirus promoters and constructs thereof |
| 04/26/2007 | US20070094745 Cotton cultivar DP 164 B2RF |
| 04/26/2007 | US20070094744 A novel stay-green gene and method for preparing stay-green transgenic plants |
| 04/26/2007 | US20070093653 siRNA targeting MCL1 |
| 04/26/2007 | US20070093650 Nucleic acid and proteins showing increased expression dose under salt stress |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093443 Modified proteases that inhibit complement activation |
| 04/26/2007 | US20070093442 Modulation of mesenchymal and metastatic cell growth |
| 04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
| 04/26/2007 | US20070093440 Gene expression inhibition by targeting a component of a human Notch signalling pathway other than presenilin1 or presenilin2 with a RNA interference ( RNAi ) agent; modulating immune responses; targeting T-cells, B-cells and antigen presenting cells; antiallergens; immunotherapy |
| 04/26/2007 | US20070093438 using a nucleic acid molecule in a screening assay for the identification of antiproliferative drug, and performing a functional analysis for the spindle formation or microtubule function during cell division; small interfering RNAs |
| 04/26/2007 | US20070093437 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 04/26/2007 | US20070093436 Drop1, a novel marker for carcinogenesis |
| 04/26/2007 | US20070093435 Modulation of cell phenotype by inhibitory rna |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070093413 Histone deacetylases, and uses related thereto |
| 04/26/2007 | US20070092968 Novel hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes |
| 04/26/2007 | US20070092956 Methods and materials for the production of organic products in cells of Candida species |
| 04/26/2007 | US20070092955 Fermentative production of lipids on an industrial scale using chemically defined media |
| 04/26/2007 | US20070092954 Production of polyketides |
| 04/26/2007 | US20070092953 Method for producing l-glutamine by fermentation and l-glutamine producing bacterium |
| 04/26/2007 | US20070092952 Glutamate 2,3-aminomutases and methods of use thereof |
| 04/26/2007 | US20070092951 Alleles of the zwf gene from coryneform bacteria |
| 04/26/2007 | US20070092948 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells |
| 04/26/2007 | US20070092946 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 04/26/2007 | US20070092945 Phospholipase |
| 04/26/2007 | US20070092944 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 04/26/2007 | US20070092943 Versatile vectors for expression of foreign proteins in photosynthetic bacteria |
| 04/26/2007 | US20070092941 PRO1298 polypeptides |
| 04/26/2007 | US20070092940 Cysteine engineered antibodies and conjugates |